+34 679 490 537info@nanbiosis.com

JUMISC

Nanbiosis

Jesus Uson Minimally Invasive Surgery Centre (JUMISC) is an institution intended for applied research, training and technology transfer in the field of minimally invasive surgery. JUMISC, close to the city centre, is placed on road N-521, Km. 41.8, near A-58 Trujillo-Caceres highway and the campus of the University of Extremadura, the new Hospital of Caceres and near the PCTEX (Science and Technology Park of Extremadura) and it’s encompassed within the City of Health Project, which is promoted by JUMISC itself. The Jesus Uson Minimally Invasive Surgery Center of Cáceres started its activity in its actual location in 2007. This institution is fully dedicated to research and training in minimally invasive surgery technologies and is managed by a public consortium constituted by the Junta de Extremadura, the Universidad de Extremadura, the Diputación Provincial de Cáceres and a private foundation formed by public and private entities. Mission and vision Jesus Uson Minimally Invasive Surgery Centre’s goals are the promotion of research and innovation and technological development in healthcare. The main objectives of the centre are:

  • To generate knowledge in the field of minimally invasive surgery and related technologies, through the performance of research activities, including the translational type, in collaboration with hospitals, institutions, companies or professionals at national and international levels.
  • To provide healthcare professionals with the acquired knowledge about minimally invasive surgery and related technologies through continuous improvement and update of the activity of dissemination and diffusion of technologies and surgical techniques.
  • To offer the experimental resources (physical, human and procedural) available at the centre to companies, hospitals, technical institutes or other agents in their research and clinical application in order to get more efficient products and processes or improve the existing.
  • To boost the creation of new technology-based companies and offer consultancy services for existing companies in technology and innovation management.
  • To disseminate and take advantage of the knowledge generated in the Centre through intangible or tangible results such as patents and utility models that will become marketable products and processes, as well as scientific publications.

The main strategic lines of research that formed JUMISC’s research programme are structured into 5 main areas: Minimally invasive surgery, Cell Therapy, Bioengineering, Pharmacy and Assisted Reproduction. The competitive funding that JUMISC was able to raise through their research groups, grew significantly in the first years of JUMISC

ICTS de CCMIJU


Nanbiosis